← Leaderboards
Zhiheng Pei
New York University School Of Medicine
$10,624,442
Attributed
$19,720,449
Total exposure
10
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2005–20$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$19,720,449 · 10
By mechanism
R01$9,156,511 · 5
UH3$6,129,278 · 1
U01$2,696,280 · 1
UH2$1,080,286 · 1
R21$658,094 · 2
Top collaborators
- Jiyoung Ahn5 shared
- Yu Chen5 shared
- Richard Bernard Hayes5 shared
- Karen E. Nelson5 shared
- Xiao-Ou Shu5 shared
- Theresa L Chang3 shared
- Liying Yang2 shared
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Jiyoung Ahn$11,904,977
- Richard Bernard Hayes$7,406,813
- Stella Kang$5,102,891
- Liying Yang$1,264,876
Others in their field
Top investigators on “Sampling”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$522,319,685
- David R. Weir · University Of Michigan At Ann Arbor$421,002,438
- David Heimbrook · Leidos Biomedical Research, Inc.$410,224,927
- Eric S Lander · Whitehead Institute For Biomedical Res$395,613,296
- Richard A Gibbs · Baylor College Of Medicine$356,778,395
Research focus
SamplingMicrobiomeOral CavityRisk FactorsCase-Control StudiesEtiologyPrimitive Foregut StructureMicrobialMetagenomicsPublic Health RelevanceBasePreventOralLeadLinkDesignProspective StudiesDiagnosisStomachGenesHuman MicrobiomeCancer RiskNested Case-Control StudyEsophagus
Grant awards (36)
Foregut Microbiome and Risk of Gastric Intestinal Metaplasia, and Gastric Cancer Risk$665,840
R01 · FY2020 · CA
Foregut Microbiome and Risk of Gastric Intestinal Metaplasia, and Gastric Cancer Risk$642,576
R01 · FY2019 · CA
Foregut Microbiome and Risk of Gastric Intestinal Metaplasia, and Gastric Cancer Risk$759,503
R01 · FY2018 · CA
Oral microbiome in esophageal adenocarcinoma$539,256
U01 · FY2018 · CA · contact PI
Foregut Microbiome and Risk of Gastric Intestinal Metaplasia, and Gastric Cancer Risk$888,388
R01 · FY2017 · CA
Oral microbiome in esophageal adenocarcinoma$539,256
U01 · FY2017 · CA · contact PI
Foregut Microbiome and Risk of Gastric Intestinal Metaplasia, and Gastric Cancer Risk$877,320
R01 · FY2016 · CA
Oral microbiome in esophageal adenocarcinoma$539,256
U01 · FY2016 · CA · contact PI
Role of HPV in oral cavity squamous cell carcinoma$217,870
R21 · FY2016 · DE · contact PI
Oral microbiome in esophageal adenocarcinoma$539,256
U01 · FY2015 · CA · contact PI
The Oral Microbiome and Upper Aerodigestive Squamous Cell Cancer$350,675
R01 · FY2015 · CA
Role of HPV in oral cavity squamous cell carcinoma$192,870
R21 · FY2015 · DE · contact PI
Modulation of innate immunity,microbiome and HIV transmission by Depo-Provera$21,091
R01 · FY2015 · AI
Foregut microbiome in development of esophageal adenocarcinoma$1,033,316
UH3 · FY2014 · CA · contact PI
Modulation of innate immunity,microbiome and HIV transmission by Depo-Provera$561,750
R01 · FY2014 · AI
Oral microbiome in esophageal adenocarcinoma$539,256
U01 · FY2014 · CA · contact PI
The Oral Microbiome and Upper Aerodigestive Squamous Cell Cancer$276,844
R01 · FY2014 · CA
Modulation of innate immunity,microbiome and HIV transmission by Depo-Provera$522,582
R01 · FY2013 · AI
The Oral Microbiome and Upper Aerodigestive Squamous Cell Cancer$329,635
R01 · FY2013 · CA
Foregut microbiome in development of esophageal adenocarcinoma$1,377,812
UH3 · FY2012 · CA · contact PI
The Oral Microbiome and Upper Aerodigestive Squamous Cell Cancer$350,675
R01 · FY2012 · CA
Foregut microbiome in development of esophageal adenocarcinoma$1,457,134
UH3 · FY2011 · CA · contact PI
The Oral Microbiome and Upper Aerodigestive Squamous Cell Cancer$350,675
R01 · FY2011 · CA
Foregut microbiome in development of esophageal adenocarcinoma$2,261,016
UH3 · FY2010 · CA · contact PI
Foregut microbiome in development of esophageal adenocarcinoma$1,080,286
UH2 · FY2009 · CA · contact PI
Etiology & pathogenesis of chronic tonsillar hypertrophy$314,396
R01 · FY2009 · AI · contact PI
Etiology & pathogenesis of chronic tonsillar hypertrophy$314,396
R01 · FY2008 · AI · contact PI
Etiology & pathogenesis of chronic tonsillar hypertrophy$320,485
R01 · FY2007 · AI · contact PI
Etiology & pathogenesis of chronic tonsillar hypertrophy$330,057
R01 · FY2006 · AI · contact PI
Etiology &pathogenesis of chronic tonsillar hypertrophy$329,800
R01 · FY2005 · AI
Bacterial flora in normal esophagus &reflux disorders$254,664
R01 · FY2005 · CA
Bacterial flora in normal esophagus &reflux disorders$231,400
R01 · FY2004 · CA
Bacterial flora in normal esophagus &reflux disorders$231,878
R01 · FY2003 · CA
Bacterial flora in normal esophagus &reflux disorders$231,881
R01 · FY2002 · CA
SEARCHING FOR EVIDENCE OF INFECTION IN CROHN'S DISEASE$123,677
R21 · FY2001 · DK
SEARCHING FOR EVIDENCE OF INFECTION IN CROHN'S DISEASE$123,677
R21 · FY2000 · DK